article thumbnail

The Economics of Investigational Device Exemption (IDE) Studies: What You Need to Know About Medicare Coverage

The Premier Consulting Blog

This article reviews the regulations governing charging or obtaining insurance coverage for an investigational device. 2] Code of Federal Regulations. 3] Code of Federal Regulations. Resources [1] US Food and Drug Administration. Investigational Device Exemption. Available at [link]. [2] Available at [link]. [3] Application.

article thumbnail

The Gig Economy, Nightwork, and Stimulant Use

Common Sense for Drug Policy Blog

Melatonin, the hormone involved in the regulation of our biological clock, is released when we are exposed to daylight. "But working at night is not necessarily good for us.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article Periodic Thank You EPA publishes draft Meaningful Involvement Policy

Agency IQ

EPA publishes draft Meaningful Involvement Policy The Environmental Protection Agency has released a draft of its Meaningful Involvement Policy, an update of a 2003 policy, which seeks to improve the interactions of the agency with stakeholders about agency actions. To contact the author of this analysis, please email Walker Livingston.

article thumbnail

Drugs Companies Clap Back at Congress…Then Get Sued

FDA Law Blog: Biosimilars

In fact, federal law and regulation appear to require AbbVie to list these patents.” Kaleo also delisted, but not without noting that “the decision to list each of these patents was proper, consistent, and required by the applicable statutes, regulations, and FDA’s guidance available at the time of listing.”

Drugs 59
article thumbnail

Biophytis Announces Plan to Publicly File Later Today Registration Statement for Proposed Initial Public Offering in the United States

The Pharma Data

This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to any securities of Biophytis in any country.

article thumbnail

Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

The Pharma Data

with Xolair since its initial approval in 2003. By reducing free IgE, down-regulating high-affinity IgE receptors and limiting mast cell degranulation, Xolair minimizes the release of mediators throughout the allergic inflammatory cascade. Approximately 460,000 patients have been treated in the U.S. In the U.S., About Xolair.

article thumbnail

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA

FDA Law Blog: Biosimilars

It merely says that “[t]he Hatch-Waxman Act and FDA regulations set forth the criteria for listing patents in the Orange Book” and that “Brand manufacturers are responsible for ensuring their patents are properly listed.” But it is not always clear which types of patents are eligible for listing in the Orange Book.

FDA 105